Global /China /Healthcare /Drug Manufacturers - General /301277

Newland Pharmaceutical Co., Ltd.

301277

• SHE: 301277 • Delayed

11.53CNY 0%

1.70 USD

As of 15 June 2026, Newland Pharmaceutical Co., Ltd. has a market cap of $667.16M USD, ranking #13230 globally and #3994 in China. It ranks #1198 in the Healthcare sector, and #443 in the Drug Manufacturers - General industry.

Global Rank

13230

Country Rank

3994

Sector Rank

1198

Industry Rank

443

Key Stats

Market Cap

$667.16MUSD

4.52B CNY

Enterprise Value

$569.74MUSD

3.86B CNY

Revenue (TTM)

$97.33MUSD

659.54M CNY

EBITDA (TTM)

$23.09MUSD

156.25M CNY

Net Income (TTM)

$14.87MUSD

100.78M CNY

EBITDA Margin

24%

Profit Margin

15%

PE Ratio

44.7

PS Ratio

6.9

PB Ratio

2.8

EV/EBITDA

24.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Luwei Zhang open_in_new

Employees

981

Founded

2005

Website

newlandpharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-1.7%	-1.8%	-8.1%	-12%	-2.2%	-2.4%	4.8%	-45%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	301277 河南新天地药业股份有限公司 Class A ISIN: CNE1000065K2 Shares Out.: Shares Outstanding: 392.078M¹ Shares Float: 376.103M² TV: TradingView: SZSE: 301277 SA: Stock Analysis: SHE: 301277 YF: Yahoo Finance: 301277.SZ GF: Google Finance: SHE: 301277 BA: Barron's: 301277 MS: Morningstar: XSHE: 301277	11.53 CNY	TV: TradingView: SZSE: 301277 SA: Stock Analysis: SHE: 301277 YF: Yahoo Finance: 301277.SZ GF: Google Finance: SHE: 301277 BA: Barron's: 301277 MS: Morningstar: XSHE: 301277

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Newland Pharmaceutical Co., Ltd.

Newland Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China. The company offers pharmaceutical intermediates, including L-4-hydroxyphenylglycine methyl ester, L-hydroxyphenylglycine potassium salt, L-4-hydroxyphenylglycine, and p-Toluenesulfonic acid. It also provides APIs, such as ropivacaine hydrochloride, naphazoline hydrochloride, moxifloxacin hydrochloride, lidocaine hydrochloride, vildagliptin, tadalafil, chlorpheniramine maleate, clopidogrel bisulfate, lidocaine, gatifloxacin, febuxostat, esomeprazole sodium, and esomeprazole magnesium. The company was formerly known as Henan Newland Pharmaceutical Co., Ltd. and changed its name to Newland Pharmaceutical Co., Ltd. in June 2023. Newland Pharmaceutical Co., Ltd. was founded in 2005 and is based in Changge, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 8K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 7K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 4K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 3K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 114K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 82K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 54K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 48K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 43K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 41K%	20.5	Switzerland

chevron_leftBack